This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (16)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurology  • Screening  • Neurocutaneous Diseases  • Dermatologic Disorders, Other  • Alert me on articles by topic

Marga Lammert, MD; Jan M. Friedman, MD; Lan Kluwe, PhD; Victor F. Mautner, MD

Arch Dermatol. 2005;141:71-74.

Objective  To determine the prevalence of neurofibromatosis 1 (NF1) among 6-year-old children in Germany.

Setting and Patients  A total of 152819 children aged 6 years in 6 German states were screened for NF1 during routine medical examinations at elementary school enrollment in cooperation with local health departments in 2000 and 2001.

Main Outcome Measure  The prevalence of NF1 among 6-year-old German children was estimated to be 1:2996 (95% confidence interval, 1:2260 to 1:3984).

Results  Fifty-one NF1 cases were identified and confirmed by evaluation by appropriate medical specialists. Seven other children were found to have multiple café au lait spots without other apparent features of NF1. A minimum estimate of the crude prevalence was 3.0 per 10 000 (95% confidence interval, 2.3-4.0 per 10 000 population). The incidence of NF1 in this population was probably in the range of 30 to 38 cases per 100 000 live births.

Conclusion  Our study obtained a nearly unbiased birth incidence of NF1 of approximately 1 in 2600 to 1 in 3000 and demonstrates that NF1 can be diagnosed by age 6 years in most cases by routine physical examination with special attention to the disease-associated skin stigmata.

Author Affiliations: Department of Maxillofacial Surgery, University Hospital Eppendorf, Hamburg, Germany (Drs Lammert, Kluwe, and Mautner); and Department of Medical Genetics, University of British Columbia, Vancouver (Dr Friedman).

RELATED ARTICLE

Screening School-aged Children for Neurofibromatosis 1: Dermatology or Economics and Public Policy?
Vincent M. Riccardi
Arch Dermatol. 2005;141(1):78-79.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Value of PET in the Assessment of Patients with Neurofibromatosis Type 1
Bredella et al.
Am. J. Roentgenol. 2007;189:928-935.
ABSTRACT | FULL TEXT  

NF1 Gene Expression in Mouse Fracture Healing and in Experimental Rat Pseudarthrosis
Kuorilehto et al.
J. Histochem. Cytochem. 2006;54:363-370.
ABSTRACT | FULL TEXT  

Screening School-aged Children for Neurofibromatosis 1: Dermatology or Economics and Public Policy?
Riccardi
Arch Dermatol 2005;141:78-79.
FULL TEXT